Epigral

Epigral FCF/Debt

The Free Cash Flow to Debt Ratio of Epigral (EPIGRAL.NS) as of Oct 20, 2026 is 41.49 %. In the previous year, Free Cash Flow to Debt Ratio was -0.08 % — a change of -50,761.95% (higher).

FCF/Debt

41.49 %

YoY

-50,761.95%

Last updated:

Free Cash Flow to Debt Ratio of Epigral is 2025 41.49 % . Free Cash Flow to Debt Ratio of Epigral was 2024 -0.08 % . It decreases by -50,761.95% higher compared to the previous year.

The Epigral FCF/Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF/Debt
Date
FCF/Debt
Jan 1, 2018
136.54 INR
Jan 1, 2019
-10.60 INR
Jan 1, 2020
-38.56 INR
Jan 1, 2021
5.98 INR
Jan 1, 2022
-22.05 INR
Jan 1, 2023
23.86 INR
Jan 1, 2024
-0.08 INR
Jan 1, 2025
41.49 INR
The Epigral FCF/Debt history
YEARFCF/DebtYoY
41.49 %-50,761.95%
-0.08 %-100.34%
23.86 %-208.22%
-22.05 %-468.73%
5.98 %-115.51%
-38.56 %+263.89%
-10.60 %-107.76%
136.54 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Epigral Stock analysis

What does Epigral do? Meghmani Finechem Ltd. generates revenue through the manufacturing and sale of chemical products including chlor alkali derivatives, CPVC resin, caustic soda, caustic potash, chlorine, hydrogen, chloromethanes, and hydrogen peroxide. The company serves industries such as alumina, textile, crop protection, refineries, pharmaceutical, paper & pulp, and soaps & detergent. Its subsidiary Meghmani Advanced Sciences Limited supports the business operations. The firm also trades agrochemical products to meet agricultural sector demands. The primary buyers of Meghmani Finechem's products are industrial clients across multiple sectors including textile, pharmaceutical, and crop protection. These customers rely on the company's chemical solutions for their production processes. The company's focus on chlor alkali and derivative manufacturing positions it as a key supplier in the chemical industry. Agrochemical trading complements its core chemical manufacturing business. Meghmani Finechem Ltd. operates with a product portfolio centered around chlor alkali and its derivatives, which are essential for various industrial applications. The company's manufacturing capabilities include producing CPVC resin and other specialty chemicals. Its subsidiaries and product range cater to both industrial and agricultural markets. The firm's revenue streams are derived from direct sales to industrial clients and agrochemical trading activities. Epigral is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Epigral stock

Free Cash Flow to Debt Ratio of Epigral is 41.49 % in 2025.

Free Cash Flow to Debt Ratio of Epigral changed from -0.08 % to 41.49 %, representing a -50,761.95% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow to Debt Ratio Epigral since 2006 – with annual values, charts, and detailed analysis.

FCF/Debt measures the percentage of total debt that could be repaid from free cash flow. It is a stricter measure than OCF/Debt as it accounts for capital expenditures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow to Debt Ratio's Epigral with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Epigral

All Key Metrics — Epigral